Cesca Therapeutics (KOOL) Stock: Gaining On Patent News


Cesca Therapeutics Inc. (NASDAQ: KOOL) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has been granted a new patent from the United States Patent and Trademark Office. Today, we’ll talk about the patent, how the stock is reacting to the news, and what we’ll be watching for with regard to KOOL ahead.

KOOL Announces The Issuance Of A New Patent

As mentioned above, Cesca Therapeutics is having an incredibly strong start to the trading session this morning after the company announced that it has been awarded a new patent. Patent number 9,821,111 is titled “Cell Separation Devices, Systems, and Methods.” This patent protects the company’s proprietary method for separating rare, therapeutically critical target cells from blood bone marrow, leukapheresis product, and other cell sources. The proprietary technology also maintains the viability of the cells under asceptic conditions. This technology is known as Bouyancy-Activated Cell Separation, or simply BACS, and is the key to the ongoing development of the CAR-TXpressTM platform developed by KOOL.

In a statement, Chris Xu, CEO at KOOL, had the following to offer:

As we vigorously pursue our goal of becoming a leading player in the emerging field of personalized medicine, including exciting new immunotherapies such as CAR-T, it is critical that the uniqueness of our innovations are recognized by the USPTO and other global intellectual property regulatory agencies… We believe our X-BACS technology, which is key to CAR-TXpress, allows us to address the unique needs of a broad range of potential partners, including CAR-T manufacturers, medical device companies, distributors and academic institutions. We are grateful to the USPTO for granting this latest patent and we look forward to further strengthening our intellectual property estate in the coming months.”

How The Stock Reacted To The News

As investors, one of the first things we learn is that the news moves the market. When a publicly-traded company like Cesca Therapeutics releases news of a newly awarded patent, we can expect to see gains in the value of the stock, and that’s exactly what we’re seeing today. Of course, our partners at Trade ideas were the first to alert us to the gains. At the moment (8:42), KOOL is trading at $3.90 per share after a gain of $0.40 per share (11.43%) thus far today.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on KOOL. In particular, we’re interested in following the story with regard to the company’s ongoing work surrounding their proprietary product known as CAR-TXpress as well as their ongoing efforts to continue to protect their intellectual property. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required


Please enter your comment!
Please enter your name here